Drug Shortage Report for TEVA-GABAPENTIN

Last updated on 2020-11-19 History
Report ID 126921
Drug Identification Number 02244514
Brand name TEVA-GABAPENTIN
Common or Proper name GABAPENTIN 300MG CAP
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) GABAPENTIN
Strength(s) 300MG
Dosage form(s) CAPSULE
Route of administration ORAL ORAL
Packaging size 100
ATC code N03AX
ATC description ANTIEPILEPTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-10-21
Estimated end date 2020-11-30
Actual end date 2020-11-18
Shortage status Resolved
Updated date 2020-11-19
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2020-11-19 French Compare
v3 2020-11-19 English Compare
v2 2020-10-22 French Compare
v1 2020-10-22 English Compare